Danaher stock holds near $202 after Q2 beat

Danaher stock is holding near $202 after a Q2 beat: revenue reached $6.26 billion, EPS came in at $1.94, and analysts still see a $228.91 average target.

Danaher Corp. (US2358511028) stock traded at $201.92 as of August 17, 2026, after the company reported second-quarter revenue of $6.26 billion and adjusted EPS of $1.94. The quarter also came in above estimates, with revenue topping the $6.12 billion consensus and EPS beating the $1.85 view by $0.09.

Q2 numbers still drive the debate

The latest quarter matters because it showed both growth and margin discipline at the same time. Revenue rose 5.5% year over year, while net margin held at 15.95% and return on equity was 11.04%.

That mix is why the stock is still trading close to the upper half of its 52-week range, which runs from $160.93 to $242.80. The share price also sits above the 50-day simple moving average of $193.14 and the 200-day simple moving average of $192.91.

Analysts keep a positive bias

Consensus expectations still lean constructive, with an average price target of $228.91 and a current fiscal-year EPS estimate of 8.53. A separate note from MarketBeat also said one research desk lowered its target to $195 while another kept an overweight view, showing the split between valuation caution and earnings support.

For investors, the cleanest comparison is the spread between the current quote and the target range. The stock at $201.92 stood below the $228.91 consensus target and close to the $202.51 opening level cited in the same market snapshot.

Bioprocessing and diagnostics

Danaher builds scientific instruments, diagnostics systems, and consumables across biotechnology, life sciences, and diagnostics. The company’s product mix matters because its reported quarter showed that recurring demand from consumables can still offset pressure in more cyclical parts of the portfolio.

Price and setup

Danaher stock changed hands at $201.92 as of August 17, 2026, with intraday volume of 1,033,137 shares and a market cap of $141.919 billion. The 1-year return was 3.58% in the Yahoo Finance market snapshot, while the year-to-date return was 11.44%.

Fact box

Company: Danaher Corp.

ISIN: US2358511028

Ticker: DHR

Exchange: NYSE

Price (as of August 17, 2026, 2:18 p.m. ET): $201.92 USD

Market cap: $141.919 billion (as of August 17, 2026)

Sector / Industry: Healthcare / Diagnostics & Research

Index membership: S&P 500

Next earnings date: October 20, 2026